DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban).

Rachel Ryu

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

Keyphrases

atrial fibrillation
direct oral anticoagulants
venous thromboembolism
pulmonary hypertension
oral anticoagulants